Impact of meal timing on cancer treatment in Alaska Native patients
Project 4: Effect of Meal Timing during Cancer Treatment in Alaska Native Patients - A Randomized Clinical Trial
This study is looking at how eating only during certain hours each day might help improve health outcomes for Alaska Native patients undergoing treatment for rectal cancer, by potentially making the treatment work better and reducing side effects.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10935391 on NIH RePORTER |
What this research studies
This research investigates how time-restricted eating (TRE) during cancer treatment can affect the health outcomes of Alaska Native patients. By combining fasting regimens with anticancer treatments, the study aims to enhance the effectiveness of the treatment while minimizing side effects. The trial will involve 100 patients with rectal cancer, comparing those who follow a TRE approach with those who do not. This approach is particularly relevant for Alaska Native individuals, who face higher rates of metabolic diseases and colorectal cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are Alaska Native individuals diagnosed with rectal cancer who are undergoing neoadjuvant treatment.
Not a fit: Patients who do not identify as Alaska Native or those with cancers other than rectal cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment outcomes and reduced side effects for Alaska Native cancer patients.
How similar studies have performed: Previous research has shown promising results with time-restricted eating in diverse populations, but this specific approach in Alaska Native patients is novel.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Figueiredo, Jane C. — Fred Hutchinson Cancer Center
- Study coordinator: Figueiredo, Jane C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.